ebook_ADHD2019

16 Rohde, Buitelaar, Gerlach & Faraone 28. Hess JL, Akutagava-Martins GC, Patak JD, Glatt SJ, Faraone SV. Why is there selective subcortical vul- nerability in ADHD? Clues from postmortem brain gene expression data. Mol Psychiatry. 2018;23(8):1787- 1793. 29. Faraone SV, Ghirardi L, Kuja-Halkola R, Lichtenstein P, Larsson H. The familial co-aggregation of attention-deficit/hyperactivity disorder and intellectual disability: a register-based family study. J Am Acad Child Adolesc Psychiatry. 2017;56(2):167-174.e1. 30. Lecendreux M, Konofal E, Cortese S, Faraone SV. A 4-year follow-up of attention-deficit/hyperactivity disorder in a population sample. J Clin Psychiatry. 2015;76(6):712-719. 31. Faraone SV, Biederman J, Doyle A, Murray K, Petty C, Adamson JJ, et al. Neuropsychological studies of late onset and subthreshold diagnoses of adult attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006;60(10):1081-7. 32. Faraone SV, Biederman J, Spencer T, Mick E, Murray K, Petty C, et al. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry. 2006;163(10):1720- 9; quiz 1859. 33. Faraone SV, Wilens TE, Petty C, Antshel K, Spencer T, Biederman J. Substance use among ADHD adults: implications of late onset and subthreshold diagnoses. Am J Addict. 2007;16 Suppl 1:24-32; quiz 33-4. 34. Faraone SV, Biederman J. Neurobiology of attention deficit hyperactivity disorder. In: Charney DS, Nes- tler EJ, editors. Neurobiology of mental illness. 2nd ed. New York: Oxford University Press; 2004.